EA200401357A1 - Болеутоляющая композиция для перорального применения с регулируемым высвобождением опиоида - Google Patents

Болеутоляющая композиция для перорального применения с регулируемым высвобождением опиоида

Info

Publication number
EA200401357A1
EA200401357A1 EA200401357A EA200401357A EA200401357A1 EA 200401357 A1 EA200401357 A1 EA 200401357A1 EA 200401357 A EA200401357 A EA 200401357A EA 200401357 A EA200401357 A EA 200401357A EA 200401357 A1 EA200401357 A1 EA 200401357A1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
survival
frozen
oral application
opioid
Prior art date
Application number
EA200401357A
Other languages
English (en)
Other versions
EA006846B1 (ru
Inventor
Любослав Разус
Ондрей Гаттнар
Иван Варга
Микулаш Легоцкий
Вера Корманова
Вера Губинова
Original Assignee
Зентива, А. С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зентива, А. С. filed Critical Зентива, А. С.
Publication of EA200401357A1 publication Critical patent/EA200401357A1/ru
Publication of EA006846B1 publication Critical patent/EA006846B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Изобретение описывает композицию и способ получения твердой фармацевтической композиции для перорального применения с регулируемым высвобождением активного вещества, которая содержит дигидрокодеин и его фармацевтически приемлемые соли в требуемом количестве, вместе с микронизированным эфиром глицерина и бегеновой кислоты, дигидратом фосфата кальция, сополимером винилпирролидона и винилацетата и натриевой солью сложного эфира фумаровой кислоты и стеарилового спирта.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200401357A 2002-04-12 2003-04-10 Болеутоляющая композиция для перорального применения с регулируемым высвобождением опиоида EA006846B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK501-2002A SK286107B6 (sk) 2002-04-12 2002-04-12 Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy
PCT/SK2003/000008 WO2003086365A1 (en) 2002-04-12 2003-04-10 Analgesical oral composition with controlled release of an opioid

Publications (2)

Publication Number Publication Date
EA200401357A1 true EA200401357A1 (ru) 2005-04-28
EA006846B1 EA006846B1 (ru) 2006-04-28

Family

ID=29247067

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200401357A EA006846B1 (ru) 2002-04-12 2003-04-10 Болеутоляющая композиция для перорального применения с регулируемым высвобождением опиоида

Country Status (13)

Country Link
EP (1) EP1494656B1 (ru)
AT (1) ATE398446T1 (ru)
AU (1) AU2003219641A1 (ru)
CZ (1) CZ20041054A3 (ru)
DE (1) DE60321672D1 (ru)
EA (1) EA006846B1 (ru)
GE (1) GEP20063991B (ru)
HU (1) HUP0500438A3 (ru)
NO (1) NO20044502L (ru)
PL (1) PL372698A1 (ru)
SK (1) SK286107B6 (ru)
UA (1) UA74991C2 (ru)
WO (1) WO2003086365A1 (ru)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750145T2 (de) * 1986-06-10 1994-11-03 Euro Celtique Sa Zusammensetzung mit kontrollierter Freisetzung von Dihydrocodein.
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
KR100889069B1 (ko) * 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
SK285128B6 (sk) * 1999-12-28 2006-07-07 Zentiva, A. S. Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy

Also Published As

Publication number Publication date
ATE398446T1 (de) 2008-07-15
SK286107B6 (sk) 2008-03-05
NO20044502L (no) 2004-10-26
EP1494656A1 (en) 2005-01-12
UA74991C2 (en) 2006-02-15
SK5012002A3 (en) 2003-11-04
AU2003219641A1 (en) 2003-10-27
CZ20041054A3 (cs) 2005-01-12
PL372698A1 (en) 2005-07-25
HUP0500438A2 (hu) 2005-08-29
HUP0500438A3 (en) 2008-03-28
WO2003086365A1 (en) 2003-10-23
EP1494656B1 (en) 2008-06-18
DE60321672D1 (de) 2008-07-31
GEP20063991B (en) 2006-12-11
EA006846B1 (ru) 2006-04-28

Similar Documents

Publication Publication Date Title
CA2582150C (en) Modified release ibuprofen dosage form
NO20065638L (no) Formuleringer med kontrollert frigivelse inneholdende vardenafil
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
CO6150127A2 (es) Formulaciones de flibanserina y metodo para fabricarlas
RU2010123282A (ru) Твердая лекарственная форма с быстрым высвобождением активного вещества, ее получение и применение
PE20030399A1 (es) Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa
ATE386508T1 (de) Feste orale dosierungsform enthaltend einen resorptionsverstärker
JP2009529561A5 (ru)
PT833618E (pt) Forma farmaceutica solida para utilizacao oral
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
DE60313359D1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
UA85359C2 (ru) Таблетка, содержащая гранулированный материал с kmd-3213
NO20064262L (no) Fast formulering av ospemifen
AP2003002763A0 (en) Controlled release formulations for oral administration
NO20013060L (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
CO5580741A2 (es) Composicion farmaceutica que comprende un agonista de receptor de 5ht1
US12472160B2 (en) Modified-release tiopronin compositions, kits and methods for treating cystinuria and related disorders
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
EA200401357A1 (ru) Болеутоляющая композиция для перорального применения с регулируемым высвобождением опиоида
UY28457A1 (es) Nueva composición
DK1255535T3 (da) Lægemiddelsammensætning med kontrolleret frisætning indeholdende tramadol-hydrochlorid
BRPI0307319B8 (pt) forma de dosagem oral para liberação controlada de droga e processo para sua preparação
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG TJ TM